Trial in progress: phase IB study of concurrent Azeliragon, a RAGE inhibitor, with craniospinal irradiation in patients with leptomeningeal metastases

azeliragon (TTP488) - Cantex Pharma

https://virtual.oxfordabstracts.com/event/74646/submission/917

Kara M. Banson; Judith D. Goldberg; Benjamin T. Cooper; Joshua Silverman; Erik P. Sulman; Stephen Marcus; Marissa Barbaro; J. Ricardo McFaline-Figueroa; Maria del Pilar Guillermo Prieto Eibl; Alexandra M. Miller; Jonathan T. Yang

Dec 2, 2025